Title: Surge in Poison Control Calls Highlights Concerns Over Popular Weight Loss Drugs
Word Count: 308
Calls to poison control centers in the United States have spiked as weight loss drugs gain popularity among individuals seeking to shed excess pounds. Between January and November 2023, U.S. poison control centers received a staggering 3,000 calls related to semaglutide, marking a jaw-dropping 1,500% increase compared to 2019.
The cause behind such a surge in calls, however, often remains undisclosed, as some individuals simply seek answers to their weight loss questions. Semaglutide is the active ingredient found in popular weight loss drugs like Wegovy, Ozempic, and Rybelsus. While Wegovy has obtained FDA approval for weight loss purposes, Ozempic and Rybelsus are Type 2 diabetes medications that are commonly used “off-label” for weight loss.
Earlier this year, the FDA issued a warning regarding off-brand versions of Ozempic and Wegovy, expressing concerns over their potential safety. The compounded form of semaglutide, an alternative to approved medications, has been associated with adverse events. In light of these concerns, the FDA advises against using compounded drugs when approved options are readily available.
The surge in poison control calls highlights the need for caution when it comes to weight loss medications. On one hand, these drugs offer promising results for individuals struggling with weight management. On the other hand, the potential risks and adverse effects associated with off-label and compounded versions must be thoroughly understood.
Experts encourage individuals considering weight loss drugs to consult with their healthcare providers before embarking on any treatment plan. It is crucial to prioritize the use of FDA-approved medications and avoid the potential dangers posed by off-brand options.
In conclusion, the alarming increase in poison control calls related to semaglutide-based weight loss drugs raises concerns over their safe usage. Weight loss drug seekers are urged to practice caution and prioritize FDA-approved options for their weight-loss journey.
Support for independent journalism like this is encouraged in order to stay informed about vital health and safety issues. Subscription support for mazmessenger’s journalism is encouraged.
“Infuriatingly humble tv expert. Friendly student. Travel fanatic. Bacon fan. Unable to type with boxing gloves on.”